Epinephrine
|
Basic information |
| Metabolite name | Epinephrine |
 | HMDB0000068 |
 |
C00788 |
 |
5816 |
| Synonyms | Adrenaline |
| No. of studies | 14 |
|
Basic information |
| Metabolite name | Epinephrine |
| HMDB0000068 |
|
C00788 |
|
5816 |
| Synonyms | Adrenaline |
| No. of studies | 14 |
|
Relationship between Epinephrine and depression (count: 14) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1005 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M1005 | Type1 | CUMS group vs. control group | Ileum | Sprague-Dawley rat | Down |
| Study M1005 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Down |
| Study M1005 | Type2 | CUMS + butyrate group vs. CUMS group | Ileum | Sprague-Dawley rat | Up |
| Study M1005 | Type2 | CUMS + fluoxetine group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M1005 | Type2 | CUMS + fluoxetine group vs. CUMS group | Ileum | Sprague-Dawley rat | Up |
| Study M1005 | Type2 | CUMS + butyrate group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M1005 | Type2 | CUMS + butyrate group vs. CUMS group | Plasma | Sprague-Dawley rat | Up |
| Study M1005 | Type2 | CUMS + fluoxetine group vs. CUMS group | Plasma | Sprague-Dawley rat | Up |
| Study M1025 | Type2 | CUMS + Bacillus licheniformis group vs. CUMS group | Brain | Sprague-Dawley rat | Up |
| Study M1130 | Type3 | paroxetine group vs. control group | Adrenal gland | Sprague-Dawley rat | Down |
| Study M145 | Type1 | model group vs. control group | Hippocampus | C57BL/6 mouse | Down |
| Study M581 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M581 | Type1 | CUMS group vs. control group | Hypothalamus | Sprague-Dawley rat | Down |
| Study M581 | Type2 | CUMS + fluoxetine group vs. CUMS group | Hypothalamus | Sprague-Dawley rat | Up |
| Study M581 | Type2 | CUMS + high dose of S. chinensis group vs. CUMS group | Prefrontal cortex | Sprague-Dawley rat | Up |
| Study M581 | Type2 | CUMS + high dose of S. chinensis group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M583 | Type1 | PSD group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M583 | Type2 | PSD group, after vs. before fluoxetine treatment | Hippocampus | Sprague-Dawley rat | Up |
| Study M674 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Down |
| Study M737 | Type1 | IBS-D group vs. control group | Urine | Human | Up |
| Study M770 | Type4 | responder group vs. non-responder group | Serum | C57BL/6 mouse | Down |
| Study M795 | Type1 | gastric cancer + ICI-118,551 + CUMS group vs. gastric cancer + ICI-118,551 group | Plasma | BALB/c nude mouse | Up |
| Study M795 | Type1 | gastric cancer + CUMS group vs. gastric cancer group | Plasma | BALB/c nude mouse | Up |
| Study M823 | Type2 | CUMS + albiflorin group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M867 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Down |
| Study M867 | Type2 | CUMS + Baihe-Dihuang Tang group vs. CUMS group | Urine | Sprague-Dawley rat | Unknown |
| Study M873 | Type1 | ovariectomy + CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M873 | Type2 | ovariectomy + CUMS + Xiang-Su volatile oil group vs. ovariectomy + CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M928 | Type1 | CUMS group vs. control group | Faece | C57BL/6 mouse | Up |